Brought to you by 
Pharmasset nets $43.7mm via private financing
11 Feb 2009
Executive Summary
Pharmasset (oral therapeutics for infectious diseases) netted $43.7mm through the registered direct offering of 4.68mm common shares at $9.73 each, an 11% discount, to a group of institutional investors. Leerink Swann was the placement agent.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- Private Investment in Public Equity
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Pharmasset nets $43.7mm via private financing
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice